AbbVie Inc. (ETR:4AB)
Germany flag Germany · Delayed Price · Currency is EUR
165.40
+4.20 (2.61%)
Apr 28, 2025, 9:04 AM CET

AbbVie Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
289,640303,313247,531267,336210,479154,647
Upgrade
Market Cap Growth
14.74%22.54%-7.41%27.01%36.10%32.54%
Upgrade
Enterprise Value
344,642365,205290,890321,748270,724219,355
Upgrade
Last Close Price
161.20166.90132.67138.42104.5371.52
Upgrade
PE Ratio
75.3474.1056.7724.2520.8741.52
Upgrade
PS Ratio
5.465.575.044.924.264.13
Upgrade
PB Ratio
93.0693.3526.3216.5315.5114.44
Upgrade
P/FCF Ratio
-17.6112.4011.7810.8911.27
Upgrade
P/OCF Ratio
-16.7011.9811.4510.5110.76
Upgrade
EV/Sales Ratio
6.836.715.925.925.485.86
Upgrade
EV/EBITDA Ratio
14.1814.1512.2011.9810.8912.69
Upgrade
EV/EBIT Ratio
20.7620.6318.2117.0015.5818.28
Upgrade
EV/FCF Ratio
-21.2014.5714.1814.0015.98
Upgrade
Debt / Equity Ratio
20.2220.225.803.745.036.65
Upgrade
Debt / EBITDA Ratio
2.462.512.262.222.714.06
Upgrade
Debt / FCF Ratio
-3.812.732.663.535.19
Upgrade
Asset Turnover
-0.420.400.410.380.38
Upgrade
Inventory Turnover
-4.034.364.935.385.96
Upgrade
Quick Ratio
-0.430.630.690.560.60
Upgrade
Current Ratio
-0.660.870.960.790.84
Upgrade
Return on Equity (ROE)
-62.29%35.20%72.40%80.95%187.69%
Upgrade
Return on Assets (ROA)
-8.49%8.07%8.86%8.31%7.65%
Upgrade
Return on Capital (ROIC)
15.33%16.13%14.47%14.46%12.78%11.53%
Upgrade
Return on Capital Employed (ROCE)
-19.00%18.20%18.50%17.70%12.00%
Upgrade
Earnings Yield
1.33%1.36%1.78%4.14%4.82%2.44%
Upgrade
FCF Yield
-5.68%8.06%8.49%9.19%8.88%
Upgrade
Dividend Yield
3.65%3.64%4.08%3.86%4.47%5.53%
Upgrade
Payout Ratio
-257.71%216.72%84.85%80.24%167.16%
Upgrade
Buyback Yield / Dilution
-0.03%-0.06%0.28%-0.06%-6.22%-12.74%
Upgrade
Total Shareholder Return
3.62%3.58%4.37%3.80%-1.75%-7.20%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.